<DOC>
	<DOCNO>NCT00276380</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness Tanakan® 240mg association Acetylsalicylic acid ( 325mg/day ) recovery neurological impairment follow ischemic stroke .</brief_summary>
	<brief_title>A Study Use Tanakan® Recovery Neurological Impairment Following Ischaemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Neurologic Manifestations</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patient single infarct carotid artery territory 3 8 day inclusion Patient moderately severe severe disability ( Modified Rankin Score 4 5 ) Patient Quick 's Test ( INR ) APPT ( activate partial prothrombin time ) test normal value laboratory Patients ischemic stroke ( CT confirm ) less 3 day 8 day prior Patient know preexistent cerebral infarction Infarct damage area big 1/3 hemisphere Patient score cutoff point Frenchay Aphasia Short Test</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>